Literature DB >> 35585423

Enterococci as Intestinal Microbiota: Investigation of Characteristics and Probiotic Potential in Isolates from Adults and Breast-Fed Infants.

Maryam Rahmani1, Fereshteh Saffari1,2, Eugen Domann3, Kurt Zimmermann4, Ladan Langroudi5, Shahla Mansouri6.   

Abstract

Enterococci act as symbionts in human gastrointestinal tract. The present study aimed to evaluate the characteristics of fecal enterococci isolated from infants and adults, and to compare them to the known probiotic bacteria, including lactobacilli species and E. faecalis Symbioflor 1. In total, sporadic distribution of virulence genes was detected among the studied enterococci. Furthermore, the frequency of genes encoding for sex pheromones (ccf and cob), collagen adhesion (ace), cell wall adhesion (efaAfs), and gelatinase (gelE) was observed to be significantly higher in those isolates obtained from infants compared to those obtained from adults. Although the ability of biofilm formation was found in all isolates, the strong biofilm formation was observed in enterococci from infants and strong correlation was observed between the capacities to form biofilm and attachment to Caco-2 cells. Cell-free culture supernatant showed some inhibitory effects on indicator strains, which were related to the production of organic acids (against P. aeruginosa and enteropathogenic E. coli) or both organic acids and proteinaceous antimicrobial agents (against L. monocytogenes and E. faecalis). Approximately, 79% and 71% of the isolates showed strong inhibitory effects on P. aeruginosa and L. monocytogenes, respectively. Unlike lactobacilli, enterococcal cell-free supernatants had no toxicity on intestinal cells. In conclusion, this study shows that some enterococcal isolates obtained from fecal microbiota have characteristics, which are comparable with the known probiotic bacteria. Therefore, these isolates should be considered to find probiotic candidate. The proteinaceous identity of antimicrobial substances derived from these isolates highlighted the probable contribution of bacteriocins into this issue.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  E. faecalis Symbioflor1; Enterococcus; Gut microbiota; Probiotics

Year:  2022        PMID: 35585423     DOI: 10.1007/s12602-022-09951-3

Source DB:  PubMed          Journal:  Probiotics Antimicrob Proteins        ISSN: 1867-1306            Impact factor:   4.609


  42 in total

Review 1.  The ecology, epidemiology and virulence of Enterococcus.

Authors:  Katie Fisher; Carol Phillips
Journal:  Microbiology       Date:  2009-04-21       Impact factor: 2.777

2.  Virulence and antimicrobial resistance in clinical Enterococcus faecium.

Authors:  Hanna Billström; Bodil Lund; Asa Sullivan; Carl Erik Nord
Journal:  Int J Antimicrob Agents       Date:  2008-08-19       Impact factor: 5.283

3.  Virulence and Antibiotic Resistance of Enterococci Isolated from Healthy Breastfed Infants.

Authors:  José M Landete; Ángela Peirotén; Margarita Medina; Juan L Arqués; Eva Rodríguez-Mínguez
Journal:  Microb Drug Resist       Date:  2017-07-14       Impact factor: 3.431

4.  Preterm infant gut colonization in the neonatal ICU and complete restoration 2 years later.

Authors:  L Moles; M Gómez; E Jiménez; L Fernández; G Bustos; F Chaves; R Cantón; J M Rodríguez; R Del Campo
Journal:  Clin Microbiol Infect       Date:  2015-06-15       Impact factor: 8.067

5.  Molecular screening of Enterococcus virulence determinants and potential for genetic exchange between food and medical isolates.

Authors:  T J Eaton; M J Gasson
Journal:  Appl Environ Microbiol       Date:  2001-04       Impact factor: 4.792

Review 6.  Probiotics-Live Biotherapeutics: a Story of Success, Limitations, and Future Prospects-Not Only for Humans.

Authors:  Mohamed Zommiti; Michael L Chikindas; Mounir Ferchichi
Journal:  Probiotics Antimicrob Proteins       Date:  2020-09       Impact factor: 4.609

Review 7.  Development of intestinal microbiota in infants and its impact on health.

Authors:  Sebastien Matamoros; Christele Gras-Leguen; Françoise Le Vacon; Gilles Potel; Marie-France de La Cochetiere
Journal:  Trends Microbiol       Date:  2013-01-14       Impact factor: 17.079

8.  In vitro evaluation of Augmentin by broth microdilution and disk diffusion susceptibility testing: regression analysis, tentative interpretive criteria, and quality control limits.

Authors:  P C Fuchs; A L Barry; C Thornsberry; T L Gavan; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

9.  Detection of virulence genes in resistant enterococci isolated from pediatric patients at high risk for nosocomial infections.

Authors:  Alireza Nateghian; Fatemeh Fallah; Zahra Daghighi; Hossein Goudarzi; Ali Hashemi; Joan L Robinson
Journal:  Diagn Microbiol Infect Dis       Date:  2016-03-31       Impact factor: 2.803

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.